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Human p21-activated kinase (Pak1) regulates actin organization
in mammalian cells
Mary Ann Sells*, Ulla G. Knaus†, Shubha Bagrodia‡, Diane M. Ambrose*, 
Gary M. Bokoch† and Jonathan Chernoff*
Background: The Rho family GTPases Cdc42, Rac1 and RhoA regulate the
reorganization of the actin cytoskeleton induced by extracellular signals such as
growth factors. In mammalian cells, Cdc42 regulates the formation of filopodia,
whereas Rac regulates lamellipodia formation and membrane ruffling, and RhoA
regulates the formation of stress fibers. Recently, the serine/threonine protein
kinase p65pak was isolated by virtue of its ability to bind to activated Cdc42 and
Rac1. Upon binding, p65pak autophosphorylates, thereby increasing its catalytic
activity towards exogenous substrates. This kinase is therefore a candidate
effector for the changes in cell shape induced by growth factors. 
Results: Here, we report that the microinjection of activated Pak1 protein into
quiescent Swiss 3T3 cells induces the rapid formation of polarized filopodia and
membrane ruffles. The prolonged overexpression of Pak1 amino-terminal mutants
that are unable to bind Cdc42 or Rac1 results in the accumulation of filamentous
actin in large, polarized membrane ruffles and the formation of vinculin-containing
focal complexes within these structures. This phenotype resembles that seen in
motile fibroblasts. The amino-terminal Pak1 mutant displays enhanced binding to
the adaptor protein Nck, which contains three Src-homology 3 (SH3) domains.
Mutation of a proline residue within a conserved SH3-binding region at the
amino terminus of Pak1 interferes with SH3-protein binding and alters the effects
of Pak1 on the cytoskeleton.
Conclusions: These results indicate that Pak1, acting through a protein that
contains an SH3 domain, regulates the structure of the actin cytoskeleton in
mammalian cells, and may serve as an effector for Cdc42 and/or Rac1 in
promoting cell motility.
Background
Many growth factors, in addition to stimulating cell
division, also cause rapid changes in cell shape. The Rho
family of small GTPases, which includes Cdc42, Rac1
and RhoA, seems to be essential in directing actin-reor-
ganization pathways that result in these changes in cell
morphology, characterized by the formation of filopodia,
lamellipodia, membrane ruffles and stress fibers [1–4].
Similar proteins are required for the establishment and
maintenance of cell polarity in budding and fission yeast
[5,6]. The molecular details of how these Rho family
GTPases are regulated are not well understood, although
several candidate regulatory proteins have been identi-
fied [7,8]. Even less is known about the mechanism by
which the activated GTPases transmit signals to the
actin cytoskeleton. Recently, two protein kinases were
isolated by virtue of their ability to bind to activated
Rac1. Both human p120ack [9] and rat p65pak [10] bind
preferentially to activated (GTP-bound) Rac1 and
Cdc42, inhibit subsequent GTPase-activating protein
(GAP) activity on these proteins, and, at least in the case
of p65pak, autophosphorylate upon binding — thereby
increasing their catalytic activity towards exogenous sub-
strates [10]. These kinases are therefore candidate effec-
tor proteins that cause cell shape changes in response to
growth factors.
Results 
In order to test whether p65pak or related proteins are part
of the signaling apparatus for cell morphogenesis, we
examined the effects of a human p65pak protein on actin
reorganization. We used the polymerase chain reaction to
identify Pak-like gene fragments from a human lympho-
cyte cDNA library, and subsequently cloned the full-
length cDNAs from the same library. One of the clones
encoded a 544 amino-acid protein, Pak1, which has 98%
identity to rat p65pak and which is expressed primarily in
brain, skeletal muscle and spleen. A second clone encoded
a ubiquitously expressed, 525 amino-acid protein, termed
Pak2, with 78% identity to rat p65pak (data not shown).
Pak1 has been well-characterized biochemically [10,11],
and so we chose to examine in detail the function of this
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kinase by testing its ability to carry out some of the known
effector functions of Cdc42 and Rac1. 
We first expressed Pak1 in Swiss 3T3 cells, and assessed
the effects on cell morphology. Quiescent cells were
microinjected with a fusion protein of Pak1 and
glutathione-S-transferase (GST–Pak-1), and studied by
time-lapse microscopy. GST–Pak1 is constitutively active
in vitro [11], possibly because of conformational changes
induced at the amino terminus of Pak1 by fusion with
GST (see below). Cells injected with GST–Pak1 rapidly
developed filopodia and lamellipodia at a leading edge
and retraction fibers at a trailing edge, suggesting that
GST–Pak1 stimulates cell movement (Fig. 1). These
effects were observed in more than 80% of injected cells.
The simultaneous development of filopodia and retraction
fibers has also been reported in Cdc42-injected cells [3].
The injection of GST or buffer alone had no discernible
effect on cell morphology. These effects were not inhib-
ited by co-injection of GST–Pak1 with dominant-negative
(N17) forms of Cdc42 or Rac1 (data not shown), consistent
with the idea that Pak1 functions downstream of these
GTPases in an actin-reorganization signaling pathway.
This notion is supported by the observation that endoge-
nous Pak1 colocalizes with filamentous (F) actin to filopo-
dia, lamellipodia and membrane ruffles in Swiss 3T3 cells
treated with platelet-derived growth factor (S.
Dharmawardhane, R.H. Daniels and G.M.B., unpublished
observations); increased physical association of Pak1 with
F-actin is also observed under these conditions.
As GST–Pak1 is susceptible to proteolytic degradation
during production and storage [11], we asked whether the
sustained expression of Pak1 from a plasmid vector
induced similar effects on cell morphology, and which fea-
tures of the protein were required for these events. We
made Pak1 with point mutations that abolish binding to
Cdc42 and Rac1 and/or alter kinase activity (Fig. 2).
Pak1L83,L86, with leucine residues were substituted for two
highly conserved histidine residues within the p21-binding
domain (PBD), was unable to bind to Cdc42 or Rac1 and
had enhanced kinase activity towards itself (Fig. 2) and
exogenous substrates (data not shown). A catalytically
inactive form of this PBD mutant (Pak1L83,L86,R299) was
constructed by replacing an essential lysine in the protein
kinase subdomain II with arginine. A second activated form
of Pak1 (Pak1E423) was generated by replacing a threonine
Figure 1
GST–Pak1 induces the formation of filopodia and lamellipodia in Swiss
3T3 cells. Quiescent Swiss 3T3 cells were injected with 200 mg ml–1
GST–Pak1. At the indicated intervals, phase-contrast micrographs
were obtained. Arrows indicate lamellipodia and arrowheads indicate
filopodia. Scale bar equals 10 mm.
(a)
 0 min
(b)
 10 min
(c)
 20 min
(d)
 25 min
Figure 2
Activity and interactions between Pak1 and
Rho family GTPases. COS1 cells were
transfected with pCMV6M bearing sequences
encoding the indicated forms of Pak. Anti-Myc
immunoprecipitates were assayed for the
presence of Pak1 by immunoblot, for binding
to Rac1 and Cdc42 by an overlay assay, and
for autokinase activity.
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residue in kinase subdomain VIII with glutamic acid.
Similar activating mutations have been made in other
serine/threonine kinases [12], and imply that this residue
may serve as a regulatory phosphorylation site. The ability
of Pak1E423 to bind to Cdc42 and Rac1 was unimpaired.
We compared the morphological effects of expressing Rho
family GTPases or Pak1 in quiescent Swiss 3T3 cells. In
agreement with previous reports [1–4], cells expressing
constitutively active mutants of Cdc42, Rac1 and RhoA pre-
dominantly formed filopodia, circumferential lamellipodia
and increased stress fibers, respectively (Fig. 3f–h). Expres-
sion of wild-type Pak1 (tagged with a Myc epitope) had
little effect on actin distribution (Fig. 3b), whereas expres-
sion of Myc-tagged Pak1L83,L86 induced a distinct pheno-
type, characterized by increased stress fibers and large,
protruding, ruffle-like structures positioned at one side of
the cell (Fig. 3c). This distinctive morphology, similar to
that of motile fibroblasts, was observed in more than 70% of
the transfected cells, and identical results were obtained
using a different cell type (REF52) and a different transfec-
tion method (plasmid microinjection). Omission of the
small, amino-terminal epitope tag gave equivalent results
(data not shown). Confocal imaging revealed that a substan-
tial fraction of the Pak1L83,L86 mutant protein was concen-
trated within these ruffle-like structures, where it
colocalized with F-actin (Fig. 4) and vinculin in focal com-
plexes (data not shown). The remainder of the Pak1L83,L86
appeared to be distributed throughout the cytoplasm, most
prominently in the perinuclear region. 
As Pak1L83,L86 does not bind to Rac1 or Cdc42, the
observed effects on actin distribution are unlikely to be
caused by increased p21–GTP levels resulting from the
protection of these GTPases from GAPs [10]. The
subcellular distributions of wild-type Pak1 and the PBD
mutant were grossly similar (data not shown), and so the
effects of these proteins on cytoskeletal architecture may
instead be due to differences in kinase activity, or to dif-
ferences in the conformation of the amino terminus, as
reflected by the inability of Pak1L83,L86 to bind p21
GTPases (Fig. 2). In order to distinguish between these
possibilities, we tested the effects of expressing the acti-
vated Pak1E423 mutant, which can bind p21. Cells express-
ing Pak1E423 were flattened and occasionally showed
filopodia (1–2 per cell) and complete loss of stress fibers
(Fig. 3d), but were otherwise similar to untransfected qui-
escent cells (Fig. 3a). In contrast, the kinase-dead
Pak1L83,L86,R299 mutant, which cannot bind p21, induced
the formation of unipolar ruffles (Fig. 3e), similar to those
observed in cells expressing Pak1L83,L86 (Fig. 3c), although
the cells expressing Pak1L83,L86,R299 were more elongated
and crescent-shaped.
In Swiss 3T3 cells, therefore, Pak1-mediated actin reorgani-
zation appears to have two components: a generalized effect
on cell shape that is dependent on the protein kinase activ-
ity of Pak1; and an effect on F-actin accumulation in local-
ized, ruffle-like structures which requires conformational
changes at the amino terminus of Pak1, but which is largely
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Figure 3
Effect of Pak1 on filamentous actin distribution. Swiss 3T3 cells were
transfected with (a) pCMV6 alone, or pCMV6 bearing sequences
encoding (b) Myc–Pak1, (c) Myc–Pak1L83,L86, (d) Myc–Pak1E423, 
(e) Myc–Pak1L83,L86,R299, (f) HA–Cdc42L61, (g) HA–RacL61 or 
(h) HA–RhoL63. 24 h post transfection, cells expressing recombinant
proteins, which were tagged with either the hemagglutinin (HA) or Myc
peptide epitope at the amino terminus, were identified by indirect
immunofluorescence. For each transfection, at least 100 antigen-positive
cells were examined. Each panel shows the actin distribution of a typical
cell expressing recombinant protein. Scale bar equals 10mm. 
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independent of its protein kinase activity. For wild-type
Pak1, such conformational changes presumably occur in
vivo upon binding to activated Cdc42 or Rac1. Microin-
jected GST–Pak1 protein, which has no mutation in the
PBD, does induce actin remodeling (Fig. 1); this effect
may be related to unfolding of the amino terminus result-
ing from fusion to the bulky GST moiety, a possibility
supported by the finding that GST–Pak1 is constitutively
active in vitro [11]. 
Which non-kinase domain on Pak1 might be affected by
binding to Rac1 or Cdc42? Amino-terminal to the PBD, all
known mammalian Paks, as well as Drosophila and
Caenorhabditis elegans Pak1, have a highly conserved,
proline-rich motif which directs interactions with proteins
that contain a Src-homology 3 (SH3) domain, such as Nck
[13–15]. We compared the ability of wild-type Pak1 and
the Pak1L83,L86 PBD mutant to bind to Nck in vitro.
Lysates from cells expressing wild-type and mutant Pak1
were overlayed on nitrocellulose filters containing defined
amounts of GST–Nck, and then analyzed for bound Pak1
by western immunoblotting. Pak1L83,L86 bound much
more avidly than wild-type Pak1 to GST–Nck, as judged
by the intensity of the signal on the immunoblots (Fig.
5a). No binding of Pak1 was detected when GST alone
was spotted on the filter in place of GST–Nck. When the
lysates were preincubated with activated recombinant
Rac1, the binding of wild-type Pak1 to GST–Nck
increased about four-fold, whereas the binding of
Pak1L83,L86 was unaffected (data not shown). Similar
results were obtained in vivo (Fig. 5b). Endogenous Nck
was immunoprecipitated from cells transfected with either
wild-type Pak1 or Pak1L83,L86 (both were tagged with a
hemagglutinin (HA)-epitope), and the immunoprecipi-
tates were examined by anti-HA immunoblotting.
Although the wild-type and mutant Pak1 were expressed
at approximately equal levels, approximately four-fold
more of the mutant Pak1 co-immunoprecipitated with
Nck. These data suggest that the proline-rich domain at
the amino terminus of Pak1 becomes more accessible to
SH3 proteins following the activation of Pak1 by Rac1,
and that this phenomenon can be elicited in the absence
of Rac1 by mutations within the nearby PBD. 
In order to determine whether the amino-terminal,
proline-rich region of Pak1 mediates any of its effects on
the cytoskeleton, we compared actin organization and
focal complex formation in cells transfected with the
PBD mutant Pak1L83,L86 or with Pak1A13,L83,L86; this
latter form of Pak1 has an additional mutation within the
amino-terminal, proline-rich region that completely abol-
ishes binding to Nck [14,15] and to several other proteins
that contain SH3 domains (J.C., unpublished observa-
tions). When expressed in Swiss 3T3 cells,
Pak1A13,L83,L86 caused an increase in stress fibers, but
failed to induce polarized membrane ruffles in the major-
ity of cells (Fig. 6k). These data indicate that the forma-
tion of polarized membrane ruffles requires the
amino-terminal, proline-rich region of Pak1. As the sub-
cellular distribution of both Pak1 mutants was similar
(data not shown), the lack of membrane ruffling in cells
expressing Pak1A13,L83,L86 does not appear to be due to a
gross mislocalization of this protein. It is possible,
however, that a subtle mislocalization of Pak1 would be
missed in these analyses, as the high level of expression
used might obscure such differences. 
The expression of either Pak1L83,L86 or Pak1A13,L83,L86
induced the formation of vinculin-containing focal com-
plexes, but these complexes were much more prominent
in cells expressing Pak1L83,L86, and were concentrated
within the ruffles of such cells (Fig. 6j,l). The vinculin-
containing focal complexes in cells expressing
Pak1L83,L86 were comparable in size and shape to those
seen in cells expressing Cdc42 or Rac1 (Fig. 6b,d), but
were distinct from the larger, arrow-head shaped adhe-
sion complexes induced by RhoA (Fig. 6f). Interestingly,
the increase in stress fibers could be blocked by co-
expression of dominant-negative (N19) RhoA (data not
shown). These results suggest that the increase in stress
fibers seen with these Pak1 mutants is mediated by the
activation of endogenous Rho. 
Discussion
The results reported here indicate that Pak1 modulates
the structure of the actin cytoskeleton and may serve as a
morphogenic effector for Cdc42 and/or Rac1 in vivo. This
Figure 4
Co-localization of Pak1 and F-actin. Swiss
3T3 cells were transfected with pCMV6
encoding Myc–Pak1L83,L86 and processed as
described in the legend to Figure 3. The
distribution of (a) F-actin and (b) Myc epitope
was examined by indirect
immunofluorescence, using confocal
microscopy. A combined image, shown in
color (c), indicates areas of colocalization in
yellow. Scale bar equals 10 mm. 
conclusion is based on the ability of Pak1 mutants, when
introduced into cells, to stimulate the formation of polarized
lamellipodia, membrane ruffles and filopodia. These effects
are independent of the action of Rac1 and/or Cdc42, as
dominant-negative (N17) forms of these GTPases were
unable to block Pak1-induced cytoskeletal responses. Also,
like Rac and Cdc42, Pak1 induces the formation of vin-
culin-containing focal complexes. 
Although we and others have shown that mammalian Paks
mediate activation of stress-activated protein kinase cas-
cades by Rac1/Cdc42 [16–19], probably via a MEKK, the
relevance of this activation to cytoskeletal rearrangements
or cell motility is not clear. In this study, we have shown
that the ability of Pak1 to regulate the actin cytoskeleton is
in part independent of its intrinsic serine/threonine kinase
activity. Pak1 constructs with a modified amino terminus
have dramatic effects on the polarity of the cytoskeleton in
Swiss 3T3 cells, whether or not they have an active catalytic
domain. Conversely, Pak1 that is not modified at the amino
terminus, but that has high levels of constitutive kinase
activity, lacks these effects. The ability of Pak1 to regulate
polarized actin assembly appears to depend on an amino-
terminal, proline-rich domain in Pak1 which has a predicted
SH3-binding motif, PXXP (single-letter amino-acid code, X
indicating any amino acid); mutation of this SH3-binding
domain inhibits the ability of Pak1 to induce the formation
of polarized membrane ruffles and focal complexes. The
importance of the amino-terminal PXXP domain for
cytoskeletal regulation by Pak1 is shown by the enhanced
binding of the highly active Pak1L83,L86 mutant and Cdc42-
activated, wild-type Pak1 to the SH3-containing Nck. Fur-
thermore, it has been established that this domain serves as
a functional SH3-binding site in vivo, interacting with the
second SH3 domain of the Nck adaptor protein [14,15].
Our data suggest that Pak1 binds a protein which contains
an SH3 domain and which regulates its localization and/or
affects actin dynamics. Interestingly, an analogous situation
has been described in Saccharomyces cerevisiae [20]. In this
species, a protein known as Bem1p binds to the yeast Pak
homolog, Ste20p, through an SH3 domain present on
Bem1p ([20] and E. Leberer, personal communication).
This interaction with Bem1p mediates a physical associa-
tion of Ste20p with F-actin and contributes to the regula-
tion of cell morphology in yeast. Although no mammalian
Bem1p homologs are known, a fission yeast homolog,
Scd2p/Ral3p [21], binds to fission yeast Pak1p (J.C.,
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Figure 5
Effect of Pak1 PBD mutations on binding to
Nck. (a) The indicated amounts (in mg) of
GST–Nck SH3 domain 2 were spotted onto
nitrocellulose. Extracts from COS1 cells
transfected with wild-type Pak1 or Pak1L83,L86
were then overlayed as described in Materials
and methods, and immunoblotted with
monoclonal anti-Myc. To the left, an anti-Myc
immunoblot is shown of the Pak1-containing
lysates used for the overlay. (b) Lysates from
NIH-3T3 cells stably transfected with HA-
tagged wild-type Pak1 or Pak1L83,L86 were
immunoprecipitated with anti-Nck antibodies
and immunoblotted with monoclonal anti-HA.
2 1 0.5 0.25 0.125
0.05 0.025 0.0125 0.005 Blank
2 1 0.5 0.25 0.125
0.05 0.025 0.0125 0.005 Blank
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unpublished observations). Therefore, it is plausible that
mammalian Paks are linked to the cytoskeleton via a
Bem1p-like protein. This physical association with actin-
binding proteins might give Pak access to key substrates,
perhaps within focal adhesions. Alternatively, as suggested
by the cytoskeletal activity of the kinase-dead Pak-1
protein (Fig. 3e), this enzyme might serve as a scaffold to
assemble additional molecules that affect actin structure.
From these other observations and our current data, we
hypothesize that the binding of activated Rac1–GTP or
Cdc42–GTP to Pak1 changes the conformation of its amino
terminus such that the SH3-binding domain is exposed
and/or has higher affinity for SH3-containing target proteins.
These putative target proteins, perhaps serving as the func-
tional equivalent of Bem1p in budding yeast, would enable
Pak1 to associate with and/or regulate F-actin. In this
model,  Pak1 acts as a bifunctional regulatory molecule,
with the amino-terminal PXXP motifs primarily regulating
polarization of the actin cytoskeleton through interactions
with SH3-containing proteins, and the catalytic carboxyl ter-
minus primarily mediating activation of the stress-activated
protein kinase cascades by Rac1/Cdc42 (Fig. 7). However,
as the phenotypes elicited by expression of kinase-active
and kinase-dead Pak1L83,L86 are not completely equivalent
(compare Fig. 3c,e), the kinase activity of this protein
may also influence some aspect of F-actin assembly,
perhaps indirectly via the phosphorylation of myosin.
The established morphogenic roles of Pak homologs in
budding and fission yeast [20,22–26], as well as the effects
of Pak expression in mammalian cells ([27] and this
study), suggest that Paks regulate cytoskeletal structure.
Are Paks, then, cytoskeletal effectors for Cdc42 and/or
Figure 6
Focal complex formation in cells expressing wild-type or mutant forms of Pak1. Actin (a,c,e,g,i,k) and vinculin (b,d,f,h,j,l) distribution in transgene-
expressing cells are shown 24 h after transfection of quiescent Swiss 3T3 with pCMV6 bearing sequences encoding (a,b) HA–Cdc42L61, (c,d)
HA–RacL61, (e,f) HA–RhoAL63, (g,h) Myc–Pak1, (i,j) Myc–-Pak1L83,L86 or (k,l) Myc–Pak1A13,L83,L86. Scale bar equals 10 mm. 
Rac? Expression of Pak1 in Swiss 3T3 cells induces a phe-
notype that differs from that elicited by Rac1 and Cdc42.
Pak1-induced filipodia and lamellipodia are polarized to
the leading edge of the cell, rather than symmetrically dis-
tributed, as is the case for Cdc42 and Rac1. The resulting
appearance of such cells is similar to that seen in motile
fibroblasts. In addition, recent mutational analyses of
Cdc42 and Rac1 have cast doubt on the roles of Pak or
other PBD-containing proteins in mediating the
cytoskeletal effects of these GTPases. Mouse fibroblasts
expressing Rac1 or Cdc42 mutants that cannot activate
Pak nevertheless form filopodia and circumferential mem-
brane ruffling, respectively [28,29]. Furthermore, a second
set of Rac1 or Cdc42 mutants that are expected to retain
the ability to activate Pak fail to induce formation of these
structures. However, neither of these experiments pre-
clude the possibility that Paks regulate the organization of
cortical actin and influence focal complex assembly. For
example, while Rac1A37,L61 and Cdc42A37,L61 (which fail to
induce ruffles or filopodia, respectively) were shown to be
capable of binding Pak1 in vitro, and of activating the Jun
N-terminal kinase (JNK) pathway in transfected COS
cells, there is as yet no evidence that endogenous Pak1 is
actually activated by these mutant GTPases in murine
fibroblasts. 
In addition to the three known mammalian Paks, Rac1 and
Cdc42 bind several other PBD-containing protein kinases,
such as ‘mixed lineage’ kinases, many of which also can
activate the JNK pathway [30–33]. Therefore, it is possible
that the activation of JNK induced by Rac1A37,L61 or
Cdc42A37,L61 in COS cells is mediated through a kinase
other than Pak1. Indeed, the relative levels of Paks versus
mixed-lineage kinases have not been described in COS
cells or in murine fibroblasts. Thus, activated Pak1 could
mediate some of the cytoskeletal effects of Rac1 or Cdc42
in specific cell types. A similar argument has been proposed
by Lamarche et al. [22] to account for the actin-reorganizing
activity of the Wiskott–Aldrich syndrome protein (WASP),
which, like Pak1, binds to Cdc42 via a conserved PBD [34].
It is also possible that, in some circumstances, Pak1 can reg-
ulate the actin cytoskeleton independently of activation by
GTPases — for example, by recruitment to the plasma
membrane in response to Nck translocation stimulated by
growth factors [14,35]. 
The phenotype of Swiss 3T3 cells expressing Pak1L83,L86
most closely resembles that seen during cell locomotion,
and preliminary data indicate that such cells in fact display
altered motility (M.A.S. and J.C., unpublished observa-
tions). The mechanism for some of these effects appears
to involve the interaction of Pak1 with an as yet uncharac-
terized SH3-containing actin regulatory protein, perhaps
related in structure or function to budding yeast Bem1p. It
is also possible that some of the effects of Pak1 on the
actin cytoskeleton are mediated indirectly through
myosin. In Acanthamoeba and Dictyostelium, Pak homo-
logues have recently been shown to phosphorylate myosin
heavy chain, stimulating its Mg⋅ATPase activity [36,37].
Myosin I contains an SH3 domain, which might provide a
binding site for Pak1 [38]. Although vertebrate myosin I
proteins lack an equivalent activating phosphorylation site
[39], a related isoform, myosin VI, does contain this site
[38]. It is also interesting to note that certain forms of
myosin II [40] and Pak1 (S. Dharmawardhane, R.H.
Daniels and G.M.B., unpublished observations) have been
localized to the leading edge of polarized cells. Finally, a
known Pak1-binding SH3 protein, such as Nck, may be
involved in the accumulation of F-actin in mammalian
cells (J.Y. Bu, R. Pappu, B. Mayer, J.C., D. Straus, and
A.C. Chan, unpublished observations). The Cdc42-
binding protein WASP also binds to Nck, and thus, with
Pak1, potentially forms part of a morphogenic signaling
apparatus in some cell types [34,41]. The identification of
proteins that interact with Pak1 promises to extend our
understanding of the role of these enzymes in eukaryotic
cell morphogenesis.
Conclusions
In Swiss 3T3 cells, the expression of Pak1 proteins
bearing mutations at the amino terminus induces the
polarized redistribution of F-actin and the formation of
focal complexes — a phenotype similar to that seen in
motile fibroblasts. Many of these effects appear to be
mediated by an SH3-binding motif located at the amino
terminus of Pak1. We propose that these mutant forms of
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Figure 7
A model for Pak1 activity. Upon binding to Cdc42 or Rac1, a
conformational change in Pak1 may unmask its amino-terminal proline-
rich domain as well as cause increased kinase activity. The exposed
proline-rich domain may then engage in productive interactions with
SH3-containing proteins which dictate localization and/or mediate
some of the cytoskeletal effects of Pak1. The kinase domain of Pak1
may also affect cytoskeletal structure through phosphorylation of
targets such as myosin, as well as mediate the activation of stress-
activated protein kinase (SAPK) cascades, probably via a MEKK.
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Pak1 mimic the effects of the endogenous, wild-type
protein, which, upon binding to activated Cdc42 or Rac1,
undergoes a conformational change that increases exposure
of the SH3-binding motif, allowing productive interactions
with downstream cytoskeletal effectors. 
Materials and methods 
Cell Culture
COS1 and Swiss 3T3 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% FBS. COS1 cells were
transfected using Lipofectamine and Swiss 3T3 cells were transfected
by a calcium phosphate method [42].
Protein preparation and microinjections 
Human Pak1 and Pak2 were cloned by standard methods from a
human lymphoblastoid cDNA library [43] (GenBank accession
numbers: Pak1, U24152; Pak2, U24153). Bacterial expression vectors
were created by subcloning cDNAs into pGEX-2T [44], and GST
fusion proteins were purified by standard techniques, and dialyzed
against phosphate-buffered saline. Cells were injected with
100 mg ml–1 GST–Pak1, with or without 500 mg ml–1 N17-Rac1, N17-
Cdc42, or N19-RhoA, and 500 mg ml–1 rat immunoglobulin G (IgG).
For time-lapse experiments, the cells were photographed at the indi-
cated intervals. In co-injection experiments, the cells were fixed 15 min
post-injection, and stained for the presence of IgG and for F-actin. 
Eukaryotic expression vectors
cDNAs encoding Pak1 and p21 GTPases were subcloned into the
epitope tag expression vectors pJ3M and pJ3H, respectively [45], then
subcloned as SalI–EcoRI fragments into pCMV6 (a modified version of
pCMV5) [46]. For some experiments, HA-tagged Pak1 was also used.
Immunofluorescence
Cells were fixed in 3.5% paraformaldehyde for 15 min, permeabilized
in 0.1% Tween-20, and blocked with 3% BSA. In Figure 1, cells were
stained for the presence of IgG (Lissamine-Rhodamine B-conjugated
goat anti-rat IgG) and for filamentous actin (0.1 mM FITC-phalloidin)
for 45 min. In Figure 3, cells were stained with mouse anti-epitope
tag antibodies, followed by Lissamine-Rhodamine-conjugated goat
anti-mouse antibodies and FITC-conjugated phalloidin. In Figure 6,
cells were stained with with rabbit anti-epitope tag and mouse anti-
vinculin antibodies, followed by Lissamine Rhodamine-conjugated
anti-rabbit antibodies (to localize cells expressing recombinant
protein), 0.1 mM FITC-conjugated phalloidin, and AMCA-conjugated
anti-mouse antibodies (to localize vinculin). Confocal microscopy was
performed using a Bio-Rad MRC 600 laser scanning confocal micro-
scope.
Binding studies 
COS1 cells (maintained in DMEM) supplemented with 10% FBS) were
transfected with control or protein-encoding plasmid DNA. 48 h post-
transfection, the cells were lysed in a buffer containing 50 mM Tris-HCl
pH 8.0, 137 mM NaCl, 1% NP40, 10% glycerol, 10 mM b-glycerol
phosphate, 1 mM Naávanadate, 1 mM PMSF, 10 mg ml–1 aprotinin. A
portion of the lysate was boiled in an equal volume of 2× SDS/PAGE
sample buffer, and the remainder was used either for in vitro binding
studies, by incubation with GST–p21 beads for 2 h at 4°C, or immuno-
precipitated with either anti-HA monoclonal antibody 12CA5 (BabCO)
or anti-Nck polyclonal sera (a gift from Ed Skolnik). Lysates and
immunoprecipitates were analyzed by immunoblot following SDS/10%
PAGE and transferred to nitrocellulose or polyvinylidine flouride (Immo-
bilon) membranes. Signals were detected using enhanced chemilumi-
nescence (Pierce). Rac1 and Cdc42 overlay assays (Fig. 2) were
performed essentially as described in [47] using 2 mg ml–1 g-
[35S]GTP-loaded Cdc42 or Rac1 for 20 min at 4°C, then 10 min at
room temperature. After washing to remove non-specific binding, the
blots were exposed to Kodak XAR film at –70°C for 24 h.
Pak1 overlay binding assays (Fig. 5a) were carried out by spotting the
indicated amount of GST–Nck-SH3 domain 2 (amino acids 101–166)
onto a nitrocellulose membrane, blocking with 5% non-fat milk, then
incubating the membrane at 4°C for 30 min with lysates from COS1
cells transfected with Myc-tagged Pak1 or Pak1L83,L86. The membrane
was then washed extensively and immunoblotted with anti-Myc anti-
bodies. Signals were detected using enhanced chemiluminescence. 
Kinase assays 
Kinase activity was assessed by incubating anti-Myc immunoprecipi-
tates in a buffer containing 25 mM Tris-HCl pH 7.5, 10 mM MgCl2,
20 mM g-[32P]ATP (5 000 cpm pmol–1) for 20 min at 30°C. The reac-
tion was terminated with SDS/PAGE sample buffer, separated by 10%
SDS/PAGE, blotted to a PVDF membrane and autoradiographed at
–70°C for 16 h.
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